SKK
CELG

Shepherd Kaplan Krochuk’s Celgene Corp CELG Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9,000
Closed -$894K – 176
2019
Q3 		$894K Hold
9,000
– – 0.65% 42
2019
Q2 		$832K Hold
9,000
– – 0.59% 48
2019
Q1 		$849K Hold
9,000
– – 0.53% 51
2018
Q4 		$577K Hold
9,000
– – 0.4% 68
2018
Q3 		$805K Sell
9,000
-5,000
-36% -$442K 0.41% 60
2018
Q2 		$1.11M Buy
14,000
+5,000
+56% +$415K 0.68% 35
2018
Q1 		$803K Buy
9,000
+6,000
+200% +$576K 0.49% 59
2017
Q4 		$313K Buy
+3,000
New +$339K 0.19% 140
2016
Q4 		– Sell
-3,582
Closed -$374K – 405
2016
Q3 		$374K Hold
3,582
– – 0.08% 174
2016
Q2 		$353K Hold
3,582
– – 0.09% 159
2016
Q1 		$359K Buy
+3,582
New +$369K 0.11% 135
2014
Q1 		– Sell
-3,860
Closed -$326K – 702
2013
Q4 		$326K Buy
3,860
+198
+5% +$15.7K 0.04% 287
2013
Q3 		$282K Buy
+3,662
New +$257K 0.05% 316

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Shepherd Kaplan Krochuk's CELG Position: Q4 2019 in Review

Shepherd Kaplan Krochuk sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,000 shares — an estimated $894K sold.

Shepherd Kaplan Krochuk first reported a position in CELG in Q3 2013 and held it in 13 quarters. The position peaked at $1.11M in Q2 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Shepherd Kaplan Krochuk reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 9,000 Celgene Corp shares in Q4 2019, an estimated $894K.
  • Shepherd Kaplan Krochuk first reported a position in Celgene Corp in Q3 2013 and held it in 13 quarters.
  • Shepherd Kaplan Krochuk's Celgene Corp position peaked at $1.11M in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2019, filed 5 Feb 2020.